Jane P. Hasselby

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.

Journal: BMC cancer

Published: March 19, 2025

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma.

Promoter hypermethylation of SFRP1 is an allele fraction-dependent prognostic biomarker in metastatic pancreatic ductal adenocarcinoma.

Journal: Frontiers in oncology

Published: January 30, 2025

Copenhagen Prospective Personalized Oncology (CoPPO)-impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting.

Copenhagen Prospective Personalized Oncology (CoPPO)-impact of comprehensive genomic profiling in more than 2000 patients in a phase I setting.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 15, 2024

DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers.

DNA methylation markers for sensitive detection of circulating tumor DNA in patients with gastroesophageal cancers.

Journal: ESMO gastrointestinal oncology

Published: October 16, 2024

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 24, 2024

Hepatic granulomas following liver transplantation: A retrospective survey, and analysis of possible microbiological etiology.

Hepatic granulomas following liver transplantation: A retrospective survey, and analysis of possible microbiological etiology.

Journal: Pathology, research and practice

Published: November 10, 2023

Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma.

Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma.

Journal: ESMO open

Published: November 06, 2023

Age-Related Decline in Pancreas Regeneration Is Associated With an Increased Proinflammatory Response to Injury.

Age-Related Decline in Pancreas Regeneration Is Associated With an Increased Proinflammatory Response to Injury.

Journal: Gastro hep advances

Published: September 22, 2023

Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study.

Prognostic value of margin clearance in total and distal pancreatectomy specimens with pancreatic ductal adenocarcinoma in a Danish population-based nationwide study.

Journal: Pathology, research and practice

Published: September 18, 2023

Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer Initiation.

Resolution of Acinar Dedifferentiation Regulates Tissue Remodeling in Pancreatic Injury and Cancer Initiation.

Journal: Gastroenterology

Published: June 26, 2023

Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.

Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.

Journal: Cancers

Published: June 02, 2023

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma.

Journal: Frontiers in oncology

Published: April 24, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026